Stock comparison
Medline Inc. is 39.5x more valuable than IRADIMED CORP by market capitalization ($49.12 B vs $1.24 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 39.5x more valuable than IRADIMED CORP by market capitalization ($49.12 B vs $1.24 B).
Market value leader
MDLN
Medline Inc. is 39.5x more valuable than IRADIMED CORP by market capitalization ($49.12 B vs $1.24 B).
Revenue leader
MDLN
IRMD: $83.81M vs MDLN: $28.43B.
Profit leader
MDLN
IRMD: $22.48M vs MDLN: $1.16T.
Margin leader
MDLN
IRMD: 26.8% vs MDLN: 4069.4% net margin.
| Metric | IRMD | MDLN |
|---|---|---|
| Market cap | $1.24 B | $49.12 B |
| US-listed rank | #2497 | #330 |
| Revenue (latest FY) | $83.81M | $28.43B |
| Net income (latest FY) | $22.48M | $1.16T |
| Net margin | 26.8% | 4069.4% |
| P/E (trailing FY) | 55.3x | 0.0x |
| SEC filings | 760 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 39.5x more valuable than IRADIMED CORP by market capitalization ($49.12 B vs $1.24 B).
In their latest fiscal years, IRADIMED CORP reported $83.81M in revenue while Medline Inc. reported $28.43B.
Full pages: IRADIMED CORP and Medline Inc., or browse the full rankings.